114 related articles for article (PubMed ID: 16687591)
1. Combination of known and unknown mechanisms confers high-level resistance to fluoroquinolones in Enterococcus faecium.
Oyamada Y; Ito H; Fujimoto K; Asada R; Niga T; Okamoto R; Inoue M; Yamagishi JI
J Med Microbiol; 2006 Jun; 55(Pt 6):729-736. PubMed ID: 16687591
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis.
Oyamada Y; Ito H; Inoue M; Yamagishi JI
J Med Microbiol; 2006 Oct; 55(Pt 10):1395-1401. PubMed ID: 17005789
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
[TBL] [Abstract][Full Text] [Related]
4. Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.
Rafii F; Park M; Novak JS
Antimicrob Agents Chemother; 2005 Feb; 49(2):488-92. PubMed ID: 15673722
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN.
Magallon A; Roussel M; Neuwirth C; Tetu J; Cheiakh AC; Boulet B; Varin V; Urbain V; Bador J; Amoureux L
J Antimicrob Chemother; 2021 Jan; 76(2):297-304. PubMed ID: 33156919
[TBL] [Abstract][Full Text] [Related]
7. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
[TBL] [Abstract][Full Text] [Related]
8. [Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes].
Piekarska K; Jagielski M
Med Dosw Mikrobiol; 2007; 59(4):329-41. PubMed ID: 18416125
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
12. High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.
Leavis HL; Willems RJ; Top J; Bonten MJ
J Clin Microbiol; 2006 Mar; 44(3):1059-64. PubMed ID: 16517894
[TBL] [Abstract][Full Text] [Related]
13. In vitro development of resistance to DX-619 and other quinolones in enterococci.
Wickman PA; Black JA; Smith Moland E; Thomson KS; Hanson ND
J Antimicrob Chemother; 2006 Dec; 58(6):1268-73. PubMed ID: 17062613
[TBL] [Abstract][Full Text] [Related]
14. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
Nakase K; Sakuma Y; Nakaminami H; Noguchi N
Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740
[TBL] [Abstract][Full Text] [Related]
15. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.
el Amin NA; Jalal S; Wretlind B
Antimicrob Agents Chemother; 1999 Apr; 43(4):947-9. PubMed ID: 10103206
[TBL] [Abstract][Full Text] [Related]
16. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
17. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
18. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
Piccinelli G; Gargiulo F; Biscaro V; Caccuri F; Caruso A; De Francesco MA
Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651
[TBL] [Abstract][Full Text] [Related]
20. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]